Haifa-Kathrin Al-Ali

16PUBLICATIONS
56CO-AUTHORS
Epidemiological modellingMolecular targetsImmunogenetics (incl. genetic immunology)Haematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 15, 2026
Risk of thromboembolic events in patients with polycythaemia vera: a study based on german health claims data.

|May 05, 2026
MDM2 inhibitors in myeloid cancers: from basic biology to clinical use in myeloproliferative neoplasms.

|Aug 28, 2025
Long-Term Immune Response to SARS-CoV-2 Vaccination in Hematologic Malignancies: An Update of the ImV-HOng Trial of the East German Study Group for Hematology and Oncology.

Susann Schulze, Sabrina Jotschke, Robby Engelmann

|Aug 05, 2025
Association of the composition of the bone marrow tumor microenvironment in BCR::ABL1-negative myeloproliferative neoplasms with IFN-γ signaling and driver mutations.

Marcus Bauer, Christoforos Vaxevanis, Nadja Jaekel

|Feb 25, 2025
Comparison of recognition of symptom burden in MPN between patient- and physician-reported assessment - an intraindividual analysis by the German Study Group for MPN (GSG-MPN).

Kirsi Manz, Florian H Heidel, Steffen Koschmieder

|Jan 09, 2025
Early intervention with ruxolitinib improves spleen response in patients with myelofibrosis.

Pankit Vachhani, Paola Guglielmelli, Jennifer Repp

Pageof 3

Frequent Collaborators

5 joint publications

Francesca Palandri

4 joint publications

Nadja Jaekel

2 joint publications

Robby Engelmann

2 joint publications

Florian H Heidel